ERBB2 and breast cancer: Recently, Grynberg et al. evaluated [18], in a multicenter retrospective study of 352 patients, the ovarian reserve indices and the response to stimulation of patients with breast cancer, finding no differences in either basal or oocyte recruitment based on the prognostic factors of the tumor (grade, triple-negative status, HER2 expression).